Thrombocytopenia Occurring During the Administration of Heparin In a group of 52 patients receiving continuous intravenous , 16 developed (platelets less than 100 000/mm3). Ten of the 16 patients who had had elevated ti... BELL,WILLIAM,R. - 《Annals of Internal Medicine》 被引量: 580发表: ...
In a group of 52 patients receiving continuous intravenous , 16 developed (platelets less than 100 000/mm3). Ten of the 16 patients who had had elevated ti... BELL,WILLIAM,R. - 《Annals of Internal Medicine》 被引量: 580发表: 1976年 加载更多来源...
There is only a small possibility of the reduction of blood platelets. There is also no change in fibrinogen binding. Compared with standard heparin, low molecular weight heparin preparations increased the bioavailability and half-life. Subcutaneous injection can lead to rapid absorption. Low ...
Blood platelets release different growth factors and chemokines to promote the survival and reproduction of tumor cells, while heparin reduces the release of tumor cell-induced mediators in a contact- and coagulation-dependent manner. Pretreatment of platelets with UFH reduces the release of vascular ...
HIT is a serious immune-mediated reaction resulting from irreversible aggregation of platelets. HIT occurs in patients treated with heparin and is due to the development of antibodies to a platelet Factor 4-heparin complex that induce in vivo platelet aggregation. HIT may progress to the development...
HIT is a serious antibody-mediated reaction resulting from irreversible aggregation of platelets. HIT occurs in patients treated with heparin and is due to the development of antibodies to a platelet Factor 4-heparin complex that induce in vivo platelet aggregation. HIT may progress to the developmen...
When introduced in combination with warfarin, an alternative anticoagulant must be continued until the International Normalised Ratio (INR) is therapeutic for two consecutive days. Platelets should not be given for prophylaxis. Lepirudin, at doses adjusted to achieve an activated partial thromboplastin ...
All four patients were discharged with an average of 47.3 ± 15.6 days. Thrombocyte counts significantly improved after the conversion of anticoagulation therapy to Argatroban (platelets count (* 1000 μL) at a minimum level during Impella use vs. 2 days after conversion: 32.8 ± 5.56 vs. ...
For the count of white blood cells (WBCs) and platelets (PLTs), blood was collected in an EDTA-stabilized tube and diluted to 1:1 with a physiological solution. Then, 3 mL of the diluted blood solution was placed in contact with 11 mg of pHEMA and pHEMA-lys. The test was carried ...
it neither causes significant changes in the overall coagulation index nor prolongs the bleeding time. There is only a small possibility of the reduction of blood platelets. There is also no change in fibrinogen binding. Compared with standard heparin, low molecular weight heparin preparations increase...